Hyoung Woo Lee Selected Research

Hyoung Woo Lee Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 10/2020 - 11/2010
5	Hyperglycemia 01/2017 - 06/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 09/2012
2	Non-alcoholic Fatty Liver Disease 12/2020 - 08/2013
2	Atherosclerosis 01/2018 - 06/2008
2	Hypertension (High Blood Pressure) 01/2018 - 08/2013
2	Insulin Resistance 09/2017 - 12/2013
2	Albuminuria 10/2016 - 04/2013
2	Hypothyroidism 07/2016 - 11/2007
2	Obesity 02/2013 - 10/2012
1	Fibrosis (Cirrhosis) 12/2020
1	Chronic Renal Insufficiency 10/2020
1	Diabetic Foot 10/2020
1	Ulcer 10/2020
1	Osteomyelitis 10/2020
1	Peripheral Arterial Disease 10/2020
1	Frailty 04/2020
1	COVID-19 01/2020
1	Diabetes Mellitus 01/2020
1	Inflammation (Inflammations) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Prediabetic State (Prediabetes) 09/2017
1	Hypoglycemia (Reactive Hypoglycemia) 04/2014
1	Weight Gain 04/2014
1	Critical Illness (Critically Ill) 10/2013
1	Neoplasms (Cancer) 04/2013
1	Coronary Stenosis (Coronary Artery Stenosis) 02/2013
1	Weight Loss (Weight Reduction) 10/2011
1	Glucose Intolerance 10/2010
1	Atrophic Muscular Disorders 01/2010
1	Muscular Dystrophies (Muscular Dystrophy) 01/2010
1	Atrophy 01/2010
1	Hypercholesterolemia 06/2008
1	Thyroid Dysgenesis (Thyroid Agenesis) 11/2007

Drug/Important Bio-Agent (IBA)

5	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 04/2013
5	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	CholesterolIBA 01/2018 - 06/2008
2	CreatinineIBA 01/2018 - 10/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 09/2012
2	Insulin (Novolin)FDA Link 01/2014 - 12/2013
2	Blood Glucose (Blood Sugar)IBA 01/2014 - 10/2013
2	oxidized low density lipoproteinIBA 04/2013 - 06/2008
1	CadmiumIBA 12/2020
1	Heavy MetalsIBA 12/2020
1	MercuryIBA 12/2020
1	lobeglitazoneIBA 10/2020
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2020
1	Alanine Transaminase (SGPT)IBA 04/2020
1	HDL CholesterolIBA 01/2018
1	Cystatin CIBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 09/2017
1	Therapeutic UsesIBA 01/2017
1	LC15-0444IBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2016
1	AlbuminsIBA 10/2016
1	Probucol (Lorelco)FDA Link 10/2016
1	Angiotensin Receptor AntagonistsIBA 10/2016
1	Insulin Glargine (Lantus)FDA Link 04/2014
1	glimepiride (Amarel)FDA LinkGeneric 04/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2014
1	voglibose (Basen)IBA 01/2014
1	Acarbose FDA LinkGeneric 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013
1	LipidsIBA 08/2013
1	Hemoglobins (Hemoglobin)IBA 08/2013
1	C-Reactive ProteinIBA 08/2013
1	LDL CholesterolIBA 04/2013
1	CalciumIBA 02/2013
1	Phenobarbital (Luminal)FDA Link 02/2013
1	Dietary Fiber FDA Link 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2011
1	VildagliptinIBA 11/2010
1	Pioglitazone (Actos)FDA Link 11/2010
1	idesolideIBA 01/2010
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 06/2008
1	Biological ProductsIBA 06/2008
1	Thyroid HormonesIBA 11/2007
1	Radioisotopes (Radionuclides)IBA 11/2007

Therapy/Procedure

2	Glycemic Control 01/2020 - 07/2016
1	Surgical Amputation (Amputations) 10/2020
1	Therapeutics 11/2010
1	Transplantation 01/2010